Reducing the Frequency of Follow-up Cystoscopy in Low-grade pTa Non–muscle-invasive Bladder Cancer Using the ADXBLADDER Biomarker

Patients with low-grade pTa non–muscle-invasive bladder cancer without carcinoma in situ at previous diagnosis are ideally suited for less intensive follow-up monitoring using the ADXBLADDER test, which would lead to a reduction in unnecessary cystoscopies for ADXBLADDER-negative patients. Non–muscl...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	European urology focus 2022-11, Vol.8 (6), p.1643-1649
Hauptverfasser:	Rouprêt, Morgan, Gontero, Paolo, McCracken, Stuart R.C., Dudderidge, Tim, Stockley, Jacqueline, Kennedy, Ashleigh, Rodriguez, Oscar, Sieverink, Caroline, Vanié, Felicien, Allasia, Marco, Witjes, J. Alfred, Colombel, Marc, Longo, Fabrizio, Montanari, Emanuele, Palou, Joan, Sylvester, Richard J.
Format:	Artikel
Sprache:	eng
Schlagworte:	ADXBLADDER Decision curve analysis Follow-up cystoscopy High-grade recurrence Humans MCM5 protein Non-Muscle Invasive Bladder Neoplasms Non–muscle-invasive bladder cancer Prospective Studies Quality of Life Recurrence Surveillance Urinary biomarker Urothelial carcinoma
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!